Toward Digital Self-monitoring of Multiple Sclerosis
Authors: Wendrich Karine , van Oirschot Pim , Martens Marijn Bart , Heerings Marco , Jongen Peter Joseph , Krabbenborg Lotte 
Published: December 2019

CME/CNE Information

Activity Available Online:
To access the article, post-test, and evaluation online, go to http://www.cmscscholar.org.

Target Audience:
The target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS).

Learning Objectives:

Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit
The CMSC designates this journal-based activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Credit
The CMSC designates this enduring material for 0.75 contact hour (none in the area of pharmacology).

Disclosures:
Editor in Chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed relationships with Springer Publishing (royalty); Qr8 (receipt of intellectual property rights/patent holder); Abide Therapeutics, GW Pharma (consulting fee); Biogen (speakers' bureau); and Adamas Pharmaceuticals (contracted research).Francois Bethoux, MD,
has served as reviewer for this activity. She has disclosed no relevant financial relationships.Laurie Scudder, DNP, NP,
has disclosed no relevant financial relationships.Karine Wendrich, MSc,
has disclosed a relationship with Orikami/MS sherpa BV (salary).Pim van Oirschot, MSc,
has disclosed no relevant financial relationships.Marijn Bart Martens, PhD,
has disclosed no relevant financial relationships.Marco Heerings, MANP,
has disclosed relationships with Bayer (educational/consultancy activities) and MS sherpa BV (consulting fee).Peter Joseph Jongen, PhD,
has disclosed no relevant financial relationships.Lotte Krabbenborg, PhD,
One peer reviewer has disclosed relationships with Genentech (consulting fee, contracted research) and Novartis (contracted research). The other peer reviewers for IJMSC have disclosed no relevant financial relationships.
The staff at IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.
Note: Financial relationships for some authors may have changed in the interval between listing these disclosures and publication of the article.

Method of Participation:
Release Date: December 1, 2019
Valid for Credit Through: December 1, 2020
In order to receive CME/CNE credit, participants must:
Statements of Credit are awarded upon successful completion of the post-test with a passing score of &gt;70% and the evaluation.

Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group.

Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.